Indication

Acinetobacter pneumonia

Acinetobacter pneumonia is a severe lower respiratory tract infection caused by aerobic, Gram-negative coccobacilli of the genus *Acinetobacter*, predominantly the *Acinetobacter baumannii* complex. Read more about Acinetobacter pneumonia

16 drugs 14 manufacturers

Advertisement

Drugs that treat it

Common Acinetobacter pneumonia therapies.

Showing 10–16 of 16 drugs

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
Hikma Pharmaceuticals USA

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
Avet Pharmaceuticals

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
AVET-NOVAPLUS

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
FRESENIUS KABI

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
MULLAN PHARMACE
Filter & compare in the drug finder →Opens the drug finder with Acinetobacter pneumonia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Acinetobacter pneumonia.

Acinetobacter pneumonia is a severe lower respiratory tract infection caused by aerobic, Gram-negative coccobacilli of the genus *Acinetobacter*, predominantly the *Acinetobacter baumannii* complex.

The disease most frequently manifests as hospital-acquired pneumonia or ventilator-associated pneumonia among critically ill, mechanically ventilated, or immunocompromised patients in intensive care units.

Pathophysiologically, it develops following bacterial colonization of the upper airway and subsequent aspiration into the pulmonary parenchyma, where capsular polysaccharides, endotoxins, and robust biofilm formation drive intense alveolar inflammation, tissue necrosis, and acute respiratory failure.

Clinically, it is characterized by new or progressive pulmonary infiltrates, purulent sputum production, hypoxemia, fever, and a pronounced propensity for multidrug resistance and hemodynamic instability.

Personalize your experience

Follow Acinetobacter pneumonia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it